MinneBio

0 followers

Established in December 2018, MinneBio has evolved into a sustainable supplier in biotechnology, specializing in enzymes such as ultra-active nuclease (Benzonase), proteinase K, and cytokines like human interleukins-2, 6, 10, 12, 15, and cell culture media. Our products serve academic research, ther... Read more

Headquarters

United States

Employees

1-10

Links


Org chart

David Liang
CEO of MinneBIO || Editor of Computational & Structural Biotechnology Journal
Collapse
No reports!

Teams

This company has no teams yet


Offices

This company has no offices yet